Evidence map›Paper›PMID 33976225›Full record

ArticleNature communications2021

The ubiquitylation of IL-1β limits its cleavage by caspase-1 and targets it for proteasomal degradation.

Swarna L Vijayaraj, Rebecca Feltham, Maryam Rashidi, Daniel Frank, Zhengyang Liu, Daniel S Simpson, Gregor Ebert, Angelina Vince, Marco J Herold, Andrew Kueh and 6 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 79 citations in OpenAlex.

  1. An ancient evolutionary origin for IL-1 cytokines.Nature ecology & evolution · 2026
    Article
  2. Review
  3. Inflammasome adaptor protein ASC is a mechanistic checkpoint in IL-1β maturation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Processing and release of endogenous immunogenic peptide signals.The Plant journal : for cell and molecular biology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Swarna L Vijayaraj *The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Rebecca Feltham *The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.ORCID 0000-0001-8376-6869
Maryam RashidiThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Daniel FrankThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Zhengyang LiuThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.ORCID 0000-0002-6114-8629
Daniel S SimpsonThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Gregor EbertThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.ORCID 0000-0002-5318-3037
Angelina VinceThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Marco J HeroldThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Andrew KuehThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Jaclyn S PearsonCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.ORCID 0000-0002-7358-4479
Laura F DagleyThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.ORCID 0000-0003-4171-3712
James M MurphyThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.ORCID 0000-0003-0195-3949
Andrew I WebbThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.ORCID 0000-0001-5061-6995
Kate E LawlorThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia. kate.lawlor@hudson.org.au.ORCID 0000-0003-0471-6842
James E VinceThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia. vince@wehi.edu.au.ORCID 0000-0001-7166-2798
The University of Melbourne · AUWalter and Eliza Hall Institute of Medical Research · AUHudson Institute of Medical Research · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interleukin-1β (IL-1β) is activated by inflammasome-associated caspase-1 in rare autoinflammatory conditions and in a variety of other inflammatory diseases. Therefore, IL-1β activity must be fine-tuned to enable anti-microbial responses whilst limiting collateral damage. Here, we show that precursor IL-1β is rapidly turned over by the proteasome and this correlates with its decoration by K11-linked, K63-linked and K48-linked ubiquitin chains. The ubiquitylation of IL-1β is not just a degradation signal triggered by inflammasome priming and activating stimuli, but also limits IL-1β cleavage by caspase-1. IL-1β K133 is modified by ubiquitin and forms a salt bridge with IL-1β D129. Loss of IL-1β K133 ubiquitylation, or disruption of the K133:D129 electrostatic interaction, stabilizes IL-1β. Accordingly, Il1b

Indexed as

Protein Processing, Post-TranslationalAnimalsCaspase 1HEK293 CellsHumansInflammasomesInflammationInterleukin-1betaLipopolysaccharidesMacrophagesMiceMice, KnockoutPrimary Cell CultureProteasome Endopeptidase ComplexProteolysisReactive Oxygen SpeciesCasp1 protein, mouseCaspase 1IL1B protein, mouseInflammasomesInterleukin-1betaLipopolysaccharidesProteasome Endopeptidase ComplexReactive Oxygen SpeciesUbiquitin

Identifiers

PMID33976225
PMCPMC8113568
OpenAlexW3160850947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.